Medical Devices Insulin Needle Pen For Diabetes

sales03@pride-cnc.com

Block D, Dianlian Science Park, Matian St., Guangming District, Shenzhen 518106, China

+8615915705962

CNC Milling Workshop CNC machining centers, high speed drill and tap center	CNC Turning Workshop Slant bed CNC turning machine, diameter range from 200 to 630mm
Laser Cutting And Welding Workshop Robot arm laser welding	Stamping Workshop Hydraulic punching machines from 30 tons to 300 tons

1. Professional Placement	2. Plastic Bags	3. Carton Boxes For Shipping
4. Professional Placement	5. Professional Shock	6. Complete Package

Diabetes Treatment Devices Have Become A New Hot Spot in the International Market.

Diabetes has become the world's highest incidence and has been spreading rapidly around the world. The World Health Organization (WHO) estimates that the total number of people with diabetes worldwide now stands at 136 million. The total number of people with diabetes worldwide is expected to reach 300 million by 2025. In the past few decades, the medical treatment of diabetes mainly by drug therapy and life control and other means. In recent years, the industry set off a wave of development of diabetes treatment devices, the following is the new some of the products.

1. "Artificial pancreas" that controls blood sugar after meals

Researchers at the University of Cambridge have developed a new type of "artificial pancreas". In fact, it is made up of a matchbox-sized blood glucose detector and an insulin pump. People with type 1 diabetes can automatically measure changes in a patient's blood sugar as long as the detector is attached to a waist belt. Once the blood sugar is measured to rise too high, the tester orders the insulin pump to start and inject insulin into the body, thus returning blood sugar to normal. This will allow people with type 1 diabetes to some extent to relieve the concern source of post-meal blood sugar control.

2. Digital insulin injection pen.

Insulin injection pen ("insulin pen") is a commonly used medical device product of drug combination. Since a Swiss company pioneered insulin pen products more than 20 years ago, manufacturers around the world have produced and sold tens of billions of insulin pens, and 27 million people with diabetes in the United States alone use insulin pens year-round. However, the biggest disadvantage of traditional insulin pens is that patients can only use them according to medical instructions, rather than deciding how much insulin they do.

Lilly, one of the world's leading insulin pen manufacturers, has launched a new insulin pen product, digital insulin pen. It is characterized by the ability to automatically store the dose of insulin injected 16 times before and to give the optimal insulin dose scheme. Clinical trials in the United States and Europe have shown that 75 percent of people with diabetes, after using this digital insulin pen, have an ideal blood sugar level and avoid post-meal high blood sugar.

3. Implanted intestinal sleeve.

A U.S. medical device company has recently developed a new type of diabetes treatment device, the implanted intestinal sleeve (commodity name Endo Barrier), according to U.S. media reports. This product is a flexible thin-film intestinal sleeve made of bioplastics. The doctor needs to implant it into the patient's small intestine with an endoscope and close it to the wall of the intestine. It works by reducing the absorption of glucose and fat balls by the small intestine, resulting in a loss of weight and a drop in blood sugar.

Clinical trials in countries such as the Netherlands have shown that obese people with type 2 diabetes lose 5kg in a matter of weeks after implanting the new product through a colonoscopy. The most obvious benefit is that after the implantation of the product, the patient's post-meal blood sugar level can be controlled within a reasonable range.

According to the manufacturer, the product, which helps patients lose weight and control their blood sugar after meals, costs $2,000 each, including surgery costs. The use of enteroscopic implants takes only 15 minutes and does not require knife surgery.

4. Insulin film pump.

Insulin pump is a common lying product for diabetes. Traditional insulin pumpsystems consist of an insulin reservoir and a few feet of tubes, which can be used in a cumbersome time. Meditronic Medical Devices has developed a permeable insulin film pump. It looks like a rubber paste (but it's thick). It is attached to the skin and can be regularly released by the skin insulin. More advanced, the insulin film agent can also automatically according to the blood sugar (with biosensors) to determine the amount of insulin, so it belongs to the intelligent insulin pump products.

5. The blood glucose meter is combined with the insulin pump.

Philips has partnered with Sony of Japan to develop a treatment that combines an electronic glucose meter with an insulin pump. The instrument uses a special liquid to contact the patient's skin and uses a biosensor to measure blood sugar. The insulin pump should then be turned on by analyzing the data from the instrument. This treatment that integrates blood glucose meters and insulin pumps is considered to be a new generation of revolutionary diabetes treatment products.

6. Implanted electrical pulse stimulation therapy device.

The introduction of new ceramic piezoelectric materials has opened up a new era of implantable therapeutic devices. Foreign manufacturers using new ceramic metal coupling materials to develop an area of only (0.5 x 0.25) inch size implantable pulse generator. After implanting it into the fat layer in the abdomen of diabetic slicing, it can periodically send electrical pulse signals that stimulate the associated nerves to promote or reduce insulin secretion, leaving blood sugar within the ideal range. At present, this advanced implantable electrical pulse signal generator is still in the development stage, if it can pass clinical trials to enter the market, will become a sharp weapon against stubborn hyperglycemia symptoms.

7. 72-hour wireless blood glucose detector.

Existing e-glucose meters can only do interval blood glucose measurement, but for some patients must continuously measure their blood glucose fluctuations in order to develop a treatment plan. Medtronics Medical Devices has developed a new device that can continuously measure a patient's blood sugar level within 72 hours. The instrument consists of a high-sensitivity biosensor and a small detector, which is very small. It can be inserted into the patient's abdominal cortex. The instrument automatically measures blood sugar every 10 seconds and records it through a monitor. After 72 hours, the doctor took off the patient's monitor for data analysis to obtain detailed information about the patient's blood sugar changes during the day and at night in order to make a judgment of the condition and carry out treatment.

Hot Tags: medical devices insulin needle pen for diabetes, China, manufacturers, suppliers, factory, wholesale, customized, made in China